Alberta Investment Management Corp (AIMCo)’s Edwards Lifesciences EW Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,730	Closed	-$4.24M	–	679
2025 Q4	$4.24M	Sell	49,730 -18,570	-27%	-$1.52M	0.03%	386
2025 Q3	$5.31M	Buy	+68,300	New	+$5.34M	0.04%	253
2024 Q4	–	Sell	-94,238	Closed	-$6.22M	–	821
2024 Q3	$6.22M	Hold	94,238	–	–	0.05%	210
2024 Q2	$8.7M	Sell	94,238 -13,600	-13%	-$1.2M	0.09%	161
2024 Q1	$10.3M	Hold	107,838	–	–	0.1%	161
2023 Q4	$8.22M	Hold	107,838	–	–	0.08%	174
2023 Q3	$7.47M	Hold	107,838	–	–	0.08%	219
2023 Q2	$10.2M	Sell	107,838 -53,970	-33%	-$4.69M	0.1%	199
2023 Q1	$13.4M	Sell	161,808 -5,427	-3%	-$427K	0.13%	166
2022 Q4	$12.5M	Sell	167,235 -44,198	-21%	-$3.41M	0.11%	203
2022 Q3	$17.5M	Sell	211,433 -13,029	-6%	-$1.25M	0.13%	152
2022 Q2	$21.3M	Buy	224,462 +30,010	+15%	+$3.11M	0.15%	137
2022 Q1	$22.9M	Sell	194,452 -31,252	-14%	-$3.51M	0.13%	167
2021 Q4	$29.2M	Hold	225,704	–	–	0.18%	123
2021 Q3	$25.6M	Hold	225,704	–	–	0.22%	102
2021 Q2	$23.4M	Sell	225,704 -423	-0.2%	-$39.9K	0.19%	116
2021 Q1	$18.9M	Buy	226,127 +25,168	+13%	+$2.13M	0.17%	136
2020 Q4	$18.3M	Sell	200,959 -29,456	-13%	-$2.44M	0.16%	137
2020 Q3	$18.4M	Sell	230,415 -12,900	-5%	-$1.01M	0.2%	114
2020 Q2	$16.8M	Sell	243,315 -5,655	-2%	-$402K	0.2%	107
2020 Q1	$15.7M	Sell	248,970 -92,148	-27%	-$6.65M	0.28%	83
2019 Q4	$26.5M	Buy	341,118 +82,218	+32%	+$6.42M	0.22%	111
2019 Q3	$19M	Sell	258,900 -600	-0.2%	-$42.1K	0.18%	131
2019 Q2	$16M	Buy	259,500 +7,500	+3%	+$454K	0.15%	147
2019 Q1	$16.1M	Hold	252,000	–	–	0.15%	148
2018 Q4	$12.9M	Sell	252,000 -64,392	-20%	-$3.26M	0.14%	159
2018 Q3	$18.4M	Sell	316,392 -16,608	-5%	-$812K	0.16%	147
2018 Q2	$16.2M	Hold	333,000	–	–	0.14%	161
2018 Q1	$15.5M	Hold	333,000	–	–	0.14%	173
2017 Q4	$12.5M	Sell	333,000 -31,500	-9%	-$1.16M	0.11%	194
2017 Q3	$13.3M	Buy	364,500 +31,500	+9%	+$1.2M	0.12%	177
2017 Q2	$13.1M	Sell	333,000 -150,000	-31%	-$5.48M	0.12%	179
2017 Q1	$15.1M	Sell	483,000 -72,000	-13%	-$2.25M	0.13%	159
2016 Q4	$17.3M	Sell	555,000 -16,500	-3%	-$535K	0.16%	142
2016 Q3	$23M	Sell	571,500 -12,000	-2%	-$452K	0.23%	114
2016 Q2	$19.4M	Buy	583,500 +20,400	+4%	+$698K	0.22%	108
2016 Q1	$16.6M	Sell	563,100 -126,900	-18%	-$3.5M	0.22%	100
2015 Q4	$18.2M	Buy	690,000 +495,504	+255%	+$12.9M	0.21%	96
2015 Q3	$4.61M	Buy	+194,496	New	+$4.69M	0.05%	348
2015 Q1	–	Sell	-95,400	Closed	-$2.02M	–	526
2014 Q4	$2.02M	Sell	95,400 -257,400	-73%	-$5.17M	0.02%	441
2014 Q3	$6.01M	Hold	352,800	–	–	0.06%	328
2014 Q2	$5.05M	Buy	+352,800	New	+$4.78M	0.05%	351

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s EW Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 49,730 shares — an estimated $4.24M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in EW in Q2 2014 and held it in 42 quarters. The position peaked at $29.2M in Q4 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Alberta Investment Management Corp (AIMCo) reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 49,730 Edwards Lifesciences shares in Q1 2026, an estimated $4.24M.
Alberta Investment Management Corp (AIMCo) first reported a position in Edwards Lifesciences in Q2 2014 and held it in 42 quarters.
Alberta Investment Management Corp (AIMCo)'s Edwards Lifesciences position peaked at $29.2M in Q4 2021.
1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.